Lixisenatide Price Comparison

View full research →
Type 2 diabetesSafety Rating 8/10

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Research details

Lixisenatide — research data

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range20 mcg once daily
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Adlyxin)
NCAA D1Not listed

Overview

About Lixisenatide

Mechanism of action

Once-daily prandial GLP-1 receptor agonist

Safety profile

Nausea, headache, hypoglycemia risk · Approved for T2DM; GI side effects; well-characterized

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Lixisenatide

Failed to fetch